Kura Oncology Officer Proposes Sale of 6,906 Shares
Morgan Stanley Smith Barney LLC is named as broker, and the shares' acquisition nature is listed as PSU.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kura Oncology, Inc. (KURA) officer Kathleen Ford reported a proposed sale of 6,906 shares of common stock with an aggregate market value of $74,308.56, with September 28, 2026 listed as the approximate sale date. The notice names Morgan Stanley Smith Barney LLC as broker and lists September 27, 2026 as the acquisition date, with “PSU” as the nature of acquisition.
Key Figures
Key Terms
Rule 144 regulatory
PSU financial
Person for Whose Account the Securities are To Be Sold regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.